Shares of Insys Therapeutics were on the rise in Thursday’s trading session after the company announced that its epinephrine nasal spray was given fast track designation from the Food & Drug Administration. The FDA has given fast track designation to Insys Therapeutics’ epinephrine nasal spray as an investigational treatment for anaphylaxis, an acute, life-threatening allergic … Continue reading “Insys Therapeutics Skyrockets on FDA Fast Track Designation”
Tag: fda news
Biotech & Pharma
Sage Shares Soar After FDA Gives Green Light for This
Shares of Sage Therapeutics were exploding in Tuesday trading after the Food and Drug Administration…
June 12, 2018
Biotech & Pharma
Trevena Soars on FDA News Over Opioid Replacement Pain Killer
Trevena shares were on fire in after hours trading on Tuesday after the biotech company…
January 2, 2018